All In Biotech

Free tool

FAERS Monitor: Docetaxel

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205934 or its brand name (Docetaxel, Docetaxel). Reports on generic versions are filed under their own applications.

Reports

68,096

Serious

53,564

79% of reports

Hospitalization

20,867

Death reported

8,969

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • alopecia16,994
  • madarosis6,718
  • hair texture abnormal5,993
  • hair colour changes5,874
  • hair disorder5,625
  • diarrhoea5,337
  • nausea3,878
  • emotional distress3,615
  • anxiety3,462
  • neutropenia3,416
  • fatigue3,285
  • febrile neutropenia3,101
  • vomiting2,825
  • malignant neoplasm progression2,800
  • disease progression2,702

Reports by year received

View as table
YearReports
2004311
2005420
2006369
2007442
2008633
2009879
2010947
20111,384
20121,780
20131,648
20141,567
20152,014
20162,284
20174,814
201810,853
20197,729
20205,641
20214,535
20224,137
20234,135
20244,612
20254,125
20262,837

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,986,063 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hair disorderSignal5,625660.9631.41,178,917
madarosisSignal6,718422.4407.51,191,892
hair colour changesSignal5,874275.0265.7847,778
hair texture abnormalSignal5,993249.7241.5820,418
alopeciaSignal16,99429.228.8426,184
febrile neutropeniaSignal3,10115.114.639,024
emotional distressSignal3,6159.59.226,734
malignant neoplasm progressionSignal2,8008.78.318,520
neutropeniaSignal3,4167.97.720,306
disease progressionSignal2,7027.26.914,156
anxietySignal3,4623.83.77,122
diarrhoeaSignal5,3372.62.55,220
vomiting2,8251.91.81,143
nausea3,8781.51.5704
fatigue3,2851.31.3241

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.